Abstract
C12H9BrClNO, monoclinic, P21/n (no. 14), a = 4.3665(3) Å, b = 22.5576(17) Å, c = 12.1286(10) Å, β = 99.028(7)°, V = 1179.84(16) Å3, Z = 4, R gt (F) = 0.0595, wR ref (F 2) = 0.1451, T = 293 K.
The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.
Crystal: | Colorless block |
Size: | 0.28 × 0.27 × 0.25 mm |
Wavelength: | Mo Kα radiation (0.71073 Å) |
μ: | 3.69 mm−1 |
Diffractometer, scan mode: | XtaLAB Synergy, ω |
θ max, completeness: | 29.6°, >99% |
N(hkl)measured, N(hkl)unique, R int: | 8608, 2921, 0.059 |
Criterion for I obs, N(hkl)gt: | I obs > 2 σ(I obs), 1526 |
N(param)refined: | 145 |
Programs: | CrysAlisPRO [1], SHELX [2], Olex2 [3] |
Atom | x | y | z | U iso*/U eq |
---|---|---|---|---|
Br1 | −0.32031 (11) | 0.55891 (2) | 0.14854 (5) | 0.0803 (3) |
Cl1 | 1.2510 (3) | 0.18517 (5) | 0.45230 (12) | 0.0791 (4) |
O1 | 0.6109 (7) | 0.36343 (13) | 0.4736 (2) | 0.0671 (8) |
N1 | 0.9196 (8) | 0.28001 (16) | 0.4700 (3) | 0.0583 (9) |
C1 | 0.8132 (10) | 0.3236 (2) | 0.5270 (4) | 0.0588 (11) |
C2 | 0.8987 (11) | 0.3315 (2) | 0.6426 (4) | 0.0701 (13) |
H2 | 0.8183 | 0.3625 | 0.6799 | 0.084* |
C3 | 1.1051 (11) | 0.2919 (3) | 0.6984 (4) | 0.0773 (14) |
H3 | 1.1686 | 0.2957 | 0.7749 | 0.093* |
C4 | 1.2188 (10) | 0.2460 (2) | 0.6404 (4) | 0.0698 (13) |
H4 | 1.3595 | 0.2186 | 0.6762 | 0.084* |
C5 | 1.1153 (10) | 0.2430 (2) | 0.5290 (4) | 0.0605 (11) |
C6 | 0.5219 (10) | 0.35531 (19) | 0.3559 (3) | 0.0587 (11) |
H6A | 0.4156 | 0.3177 | 0.3414 | 0.070* |
H6B | 0.7048 | 0.3549 | 0.3197 | 0.070* |
C7 | 0.3116 (9) | 0.40504 (18) | 0.3099 (4) | 0.0551 (10) |
C8 | 0.2212 (10) | 0.4505 (2) | 0.3749 (4) | 0.0654 (12) |
H8 | 0.2889 | 0.4504 | 0.4515 | 0.079* |
C9 | 0.0346 (10) | 0.4956 (2) | 0.3284 (4) | 0.0701 (13) |
H9 | −0.0206 | 0.5261 | 0.3729 | 0.084* |
C10 | −0.0711 (9) | 0.49553 (18) | 0.2153 (4) | 0.0606 (11) |
C11 | 0.0116 (10) | 0.45080 (19) | 0.1480 (4) | 0.0641 (12) |
H11 | −0.0602 | 0.4508 | 0.0717 | 0.077* |
C12 | 0.2030 (10) | 0.4062 (2) | 0.1966 (4) | 0.0636 (11) |
H12 | 0.2606 | 0.3760 | 0.1517 | 0.076* |
Source of material
The title compound was prepared according to the synthetic method reported previously [4]. The crude product was recrystallized from ethanol to afford colorless crystals.
Experimental details
The hydrogen atoms were assigned with isotropic displacement factors U iso(H) = 1.2 times U eq(C, aromatic ring), U iso(H) = 1.2 times U eq(CH2). The final refinement were furnished using geometrical restraints, with C–H = 0.93 Å (aromatic ring), C–H = 0.97 Å (CH2).
Comment
Both O-alkylation and N-alkylation of 2-pyridone are important making the resulting molecules to be different in their biological or pharmaceutical properties [5], [6], [7]. There are many kinds of methods for achieving the useful motif. Due to the behavior of proton shuttling and tautomer transformation in those enolizable 2-pyridones itself, often results in an ambident reactivity and these compounds are very sophisticated to handle [8]. Up to now, to set up a regio- or chemo-selective alkylation is a challenge, and the controllable and regioselective synthesis of the N-alkylation and O-alkylation are still intrigued task for many decades.
The asymmetric unit of the title structure contains one molecule (see the figure). All bond lengths and angles are in the expected ranges. The dihedral angle between the phenyl ring and the pyridine ring is 3.8 °C, indicating the slightly twisted molecular conformation.
Funding source: Natural Science Foundation of Henan Province http://dx.doi.org/10.13039/501100006407
Award Identifier / Grant number: (212300410374)
-
Author contributions: The author has accepted responsibility for the entire content of this submitted manuscript and approved submission.
-
Research funding: We thank financial support from Natural Science Foundation of Henan Province (212300410374).
-
Conflict of interest statement: The author declares no conflicts of interest regarding this article.
References
1. Agilent Technologies. CrysAlisPro Software system (version 1.171.38.41r); Agilent Technologies UK Ltd: Oxford, UK, 2015.Search in Google Scholar
2. Sheldrick, G. M. A short history of SHELX. Acta Crystallogr. 2008, A64, 112–122; https://doi.org/10.1107/s0108767307043930.Search in Google Scholar
3. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K., Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Cryst. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.Search in Google Scholar
4. Lu, Z. Q., Li, Y. Z., Ru, Y., Yang, S. J., Hao, C., Zuo, M. K., Jiao, R. K., Wu, W. L., Zhou, Y., Yao, H., Huang, N. Y., Fu, Y. Q. Coordination effect enabled palladium-catalyzed regioselective O-alkylation of 2-pyridones. Chem. Commun. 2022, 58, 1215–1218; https://doi.org/10.1039/d1cc06110k.Search in Google Scholar
5. Kawada, H., Dohara, K., Shinjo, G. Evaluation of larvicidal potency of insect growth regulator, 2-[1-methyl-2-(4-phenoxyphenoxy)ethoxy]pyridine, against the housefly, Musca domestica. Jpn. J. Sanit. Zool. 1987, 38, 317–332; https://doi.org/10.7601/mez.38.317.Search in Google Scholar
6. Peters, W., Robinson, B. L., Milhous, W. K. The chemotherapy of rodent malaria. LI. studies on a new 8-aminoquinoline, WR 238,605. Ann. Trop. Med. Parasitol. 1993, 87, 547–552; https://doi.org/10.1080/00034983.1993.11812809.Search in Google Scholar
7. Hirakawa, N., Matsumoto, H., Hosoda, A., Sekine, A., Yamaura, T., Sekine, Y. A novel histamine 2(H2) receptor antagonist with gastroprotective activity. II. Synthesis and pharmacological evaluation of 2-furfuryl-thio and 2-furfurylsulfinyl acetamide derivatives with heteroaromatic rings. Chem. Pharm. Bull. 1998, 46, 616–622; https://doi.org/10.1248/cpb.46.616.Search in Google Scholar
8. Ma, X., Gang, D. R. The Lycopodium alkaloids. Nat. Prod. Rep. 2004, 21, 752–772; https://doi.org/10.1039/b409720n.Search in Google Scholar
© 2022 Zhi-Qiang Lu, published by De Gruyter, Berlin/Boston
This work is licensed under the Creative Commons Attribution 4.0 International License.